SUMMARY OF REPORT FROM THE CENTRE FOR THE ECONOMICS OF MENTAL HEALTH, THE INSTITUTE OF PSYCHIATRY, KING’S COLLEGE LONDON

COMMISSIONED BY THE ALZHEIMER’S RESEARCH TRUST

“The prevalence of AD and the associated costs are set to rise substantially over the next 20 years.  We have estimated that assuming care patterns continue as at the present time, the cost of AD in 2021 will rise to between £10 and £20 billion in 1998/99 prices.  These costs will fall mainly to the NHS, social services and families of sufferers.”(Centre for the Economics of Mental Health – The Institute of Psychiatry) .

“Medical interventions [in Alzheimer’s disease] are becoming more promising, and with them comes the possibility that the economic burden of the disease may be lessened and, more important, clinical benefits realised.  By improving cognitive function..it is possible to reduce caregiver time, delay nursing home placement and improve quality of life” (Meek et al 1998)

 

The cost of care for major diseases in the UK

Disease Prevalence Annual Cost of Care (£ billions)
Alzheimer's 527,000 11
Stroke 124,000 3.2
Heart disease 2,053,000 4.05
Cancer 655,000 1.6

UK Spending on Research

Disease Cost of care per year (£ Billions) NHS/MRC annual research spending (£ Millions) Total annual spending on research including charities (£ Millions)
Alzheimer's 11 3.7 5.5
Stroke 3.2 5.5 9.1
Heart disease 4.05 15.5 58.4
Cancer 1.6 33.1 188.5

The total amount spent on research, by both the government and charities, into Alzheimer’s disease is only 57% of the amount spent on Stroke, 9.6% of the amount spent on heart disease and 3% of the amount spent on cancer research.

Spending on research per person per year in the UK

Disease Prevalence £ Spent per sufferer per year
Alzheimer's 527,000 11
Stroke 124,000 79
Heart disease 2,053,000 28
Cancer 655,000 289

The Alzheimer’s Research Trust has committed over £3.5 million to three strategies for funding research into Alzheimer’s disease: